Lifecore Biomedical, Inc. (LFCR): Total Liabilities
$191.91M
As of 2025-05-25
$213.41M
As of 2026-06-30
+0.9%
3-year compound annual growth
-9.2%
5-year compound annual growth
+4.3%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-05-25 | $191.91M | -4.1% | 2025-08-07, Balance as of period end |
| 2024-05-26 | $200.06M | -8.4% | 2025-08-07, Balance as of period end |
| 2023-05-28 | $218.46M | n/a | 2024-08-26, Balance as of period end |
| 2023-02-26 | $163.10M | n/a | 2024-03-20, Balance as of period end |
| 2022-11-27 | $204.83M | n/a | 2024-03-20, Balance as of period end |
| 2022-08-28 | $188.50M | n/a | 2024-03-20, Balance as of period end |
| 2022-05-29 | $186.88M | n/a | 2024-03-20, Balance as of period end |
| 2022-02-27 | $181.68M | n/a | 2024-03-20, Balance as of period end |
| 2021-11-28 | $265.88M | n/a | 2024-03-20, Balance as of period end |
| 2021-08-29 | $251.61M | n/a | 2024-03-20, Balance as of period end |
| 2021-05-30 | $299.94M | n/a | 2024-03-20, Balance as of period end |
| 2021-02-28 | $304.66M | n/a | 2024-03-20, Balance as of period end |
| 2020-11-29 | $290.07M | n/a | 2024-03-20, Balance as of period end |
| 2020-08-30 | $284.50M | n/a | 2024-03-20, Balance as of period end |
| 2020-05-31 | $310.27M | +24.6% | 2021-07-29, Balance as of period end |
| 2019-05-26 | $248.95M | +63.6% | 2020-08-14, Balance as of period end |
| 2018-05-27 | $152.14M | +16.6% | 2019-08-01, Balance as of period end |
| 2017-05-28 | $130.46M | +0.1% | 2018-08-09, Balance as of period end |
| 2016-05-29 | $130.30M | +3.1% | 2018-03-15, Balance as of period end |
| 2015-05-31 | $126.36M | +16.1% | 2016-08-01, Balance as of period end |
| 2014-05-25 | $108.86M | -1.5% | 2015-07-31, Balance as of period end |
| 2013-05-26 | $110.53M | -12.4% | 2014-08-01, Balance as of period end |
| 2012-05-27 | $126.13M | +83.9% | 2013-08-07, Balance as of period end |
| 2011-05-29 | $68.59M | n/a | 2012-08-08, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $191.91M | -4.1% |
| Xencor Inc (XNCR) | 2025-12-31 | $239.91M | -13.7% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $23.85M | -11.7% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $401.34M | +14.5% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $39.41M | -8.1% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $201.25M | +38.2% |
| UroGen Pharma Ltd. (URGN) | 2025-12-31 | $305.93M | +3.9% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $241.54M | -9.5% |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $130.07M | -6.1% |
Compare LFCR, XNCR, GYRE, KPTI side by side · Screen every company in Pharmaceutical Preparations ↗